Drawing for REVOLUTIONIZING QUALITY & EFFICIENCY IN CLINICAL RESEARCH

USPTO serial 99866013

REVOLUTIONIZING QUALITY & EFFICIENCY IN CLINICAL RESEARCH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
TMEG LAW OFFICE 104

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with REVOLUTIONIZING QUALITY & EFFICIENCY IN CLINICAL RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. O'Brian

David M. O'Brian David M. O'Brian, P.C.5007 Hartwell Dr.Houston, TX 77084United States

Goods and services

ClassDescriptionStatusFirst use
016StationeryACTIVEOct 2, 2025
041Training services in the field of training individuals to properly conduct clinical trials, to ensure patient safety and data integrityACTIVEOct 2, 2025
042Consulting services in the field of pharmaceutical researchACTIVEOct 2, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026DOCKASSIGNED TO EXAMINER—
Oct 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 4, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance